Should You Buy Canopy Growth (TSX:WEED) Ahead of Earnings?

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) has made big moves this spring, but there is anxiety in the sector ahead of its next earnings report.

| More on:
edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Canopy Growth (TSX:WEED)(NYSE:CGC) is the largest cannabis company by market cap on the TSX. In early April the company joined the S&P/TSX 60 Index, becoming the first company in the fledgling cannabis sector to do so. Canopy Growth stock gained significant momentum in April after this announcement, but it has struggled in the month of May.

Shares have dropped 18% month-over-month as of close on May 29. In mid-April, I warned investors that volatility would likely catch up to the cannabis sector before the spring was finished. Still, Canopy Growth stock has climbed 56% in 2019 so far.

Is Canopy Growth worth buying ahead of its fourth quarter fiscal 2019 results? It is expected to release its next batch of earnings on June 26. Several of the top producers have released earnings that have disappointed in the spring. Cannabis sales softened to open the calendar year as supply has continued to weigh on retailers.

Most of the top producers will have ramped up production to much larger levels by the end of the year, but in the near term the industry is still experiencing growing pains.

In its third quarter fiscal 2019 results, Canopy Growth saw revenue surge 282% year-over-year to $83 million and the company sold 10,102 kilograms of cannabis. Similar to its peers, Canopy is working feverishly to ramp up production in order to fill demand domestically and for its expanding global footprint.

In late May, the Government of Canada gave approval to Les Serres Vert Cannabis, a subsidiary of Canopy Growth, to begin cannabis production. It boasts a 700,000 square foot operating space in Mirabel, Quebec; nearly 200,000 square feet were not being used.

The most exciting development at Canopy in recent weeks was its deal with Acreage, a U.S.-based cannabis company. As it stands today, shareholders with 91% of vote shares at Acreage are poised to approve the acquisition.

Canopy CEO Bruce Linton said the language of the deal affords Canopy some flexibility, as the debate over recreational cannabis still rages south of the border. The needle is pointing in the direction of more leniency on a federal level going forward, and Acreage will give Canopy valuable access to an enormous market.

Canopy Growth stock was up 1.14% in early afternoon trading on May 30. Like many top producers in this young sector, Canopy Growth boasts a high valuation. The stock had an RSI of 40 as of this writing, putting it in neutral territory as far as this technical indicator is concerned.

Turbulence in the broader market should concern investors as we move into the summer months. In the sector’s short history, broader volatility has proven to sweep up cannabis stocks.

Canopy Growth and other top producers challenged 52-week lows in the late 2018 stock market rout. There’s a lot to like about Canopy Growth going forward, especially after its Acreage move. However, the stock is still too pricey for me ahead of its next earnings report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »